Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 21 May 2022)

 

Economic assessment of incorporating the hexavalent vaccine as part of the National Immunization Program of Peru
This study aimed to estimate the economic impact of replacing the current Peruvian primary immunization scheme for infants under 1 year old with an alternative scheme with similar efficacy, based on a hexavale…
Authors: Janice Seinfeld, María Laura Rosales, Alfredo Sobrevilla and Juan Guillermo López Yescas
Citation: BMC Health Services Research 2022 22:651
Content type: Research Published on: 16 May 2022